Biblio
“A Clinical Trial of Transcranial Electromagnetic Treatment in Alzheimer's Disease: Cognitive Enhancement and Associated Changes in Cerebrospinal Fluid, Blood, and Brain Imaging.”, J Alzheimers Dis, vol. 71, no. 1, pp. 57-82, 2019.
, “Review of the Evidence that Transcranial Electromagnetic Treatment will be a Safe and Effective Therapeutic Against Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 3, pp. 753-71, 2016.
, “Neuropathologic Correlates of White Matter Hyperintensities in a Community-Based Cohort of Older Adults.”, J Alzheimers Dis, vol. 73, no. 1, pp. 333-345, 2020.
, “Word and Picture Version of the Free and Cued Selective Reminding Test (FCSRT): Is There Any Difference?”, J Alzheimers Dis, vol. 61, no. 1, pp. 47-52, 2018.
, “Cerebrospinal Fluid Level of Aquaporin4: A New Window on Glymphatic System Involvement in Neurodegenerative Disease?”, J Alzheimers Dis, vol. 69, no. 3, pp. 663-669, 2019.
, “Memory Loss and the Onset of Alzheimer's Disease Could Be Under the Control of Extracellular Heat Shock Proteins.”, J Alzheimers Dis, vol. 63, no. 3, pp. 927-934, 2018.
, “Changes in Frailty Predict Changes in Cognition in Older Men: The Honolulu-Asia Aging Study.”, J Alzheimers Dis, vol. 53, no. 3, pp. 1003-13, 2016.
, “Epilepsy in Neurodegenerative Dementias: A Clinical, Epidemiological, and EEG Study.”, J Alzheimers Dis, vol. 74, no. 3, pp. 865-874, 2020.
, “Increased Vulnerability of the Hippocampus in Transgenic Mice Overexpressing APP and Triple Repeat Tau.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1201-1219, 2018.
, “Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker Team.”, J Alzheimers Dis, vol. 55, no. 1, pp. 19-35, 2017.
, “A 10-Year Follow-Up of Adiposity and Dementia in Swedish Adults Aged 70 Years and Older.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1325-1335, 2018.
, “Adenosine Type A2A Receptor in Peripheral Cell from Patients with Alzheimer's Disease, Vascular Dementia, and Idiopathic Normal Pressure Hydrocephalus: A New/Old Potential Target.”, J Alzheimers Dis, vol. 54, no. 2, pp. 417-25, 2016.
, “Acute Exposure of the Mediobasal Hypothalamus to Amyloid-β25-35 Perturbs Hepatic Glucose Metabolism.”, J Alzheimers Dis, 2015.
, “Self-Consciousness in Patients with Behavioral Variant Frontotemporal Dementia.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1021-9, 2016.
, “Self-Consciousness Deficits in Alzheimer's Disease and Frontotemporal Dementia.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1437-1443, 2017.
, “Effect of Probiotic Bifidobacterium breve in Improving Cognitive Function and Preventing Brain Atrophy in Older Patients with Suspected Mild Cognitive Impairment: Results of a 24-Week Randomized, Double-Blind, Placebo-Controlled Trial.”, J Alzheimers Dis, vol. 88, no. 1, pp. 75-95, 2022.
, “Subjective Cognitive Decline: Is a Resilient Personality Protective Against Progression to Objective Cognitive Impairment? Findings from Two Community-Based Cohort Studies.”, J Alzheimers Dis, vol. 89, no. 1, pp. 87-105, 2022.
, “Effects of Hypertension and Anti-Hypertensive Treatment on Amyloid-β (Aβ) Plaque Load and Aβ-Synthesizing and Aβ-Degrading Enzymes in Frontal Cortex.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1191-203, 2016.
, “Multiple Mechanisms Linking Type 2 Diabetes and Alzheimer's Disease: Testosterone as a Modifier.”, J Alzheimers Dis, vol. 59, no. 2, pp. 445-466, 2017.
, “Delineating the Efficacy of a Cannabis-Based Medicine at Advanced Stages of Dementia in a Murine Model.”, J Alzheimers Dis, vol. 54, no. 3, pp. 903-912, 2016.
, “Cannabinoid Receptor 2 Participates in Amyloid-β Processing in a Mouse Model of Alzheimer's Disease but Plays a Minor Role in the Therapeutic Properties of a Cannabis-Based Medicine.”, J Alzheimers Dis, vol. 51, no. 2, pp. 489-500, 2016.
, “Isolated Amyloid-β Pathology Is Associated with Preserved Cortical Plasticity in APOE4 Alzheimer's Disease Patients.”, J Alzheimers Dis, vol. 86, no. 2, pp. 773-778, 2022.
, “Hedonic Assessment of Odors: A Comparison of Two Sensory Scales for Use with Alzheimer's Disease Patients and Elderly Individuals.”, J Alzheimers Dis, vol. 61, no. 3, pp. 929-938, 2018.
, “Pain Assessment in Dementia: Evaluation of a Point-of-Care Technological Solution.”, J Alzheimers Dis, vol. 60, no. 1, pp. 137-150, 2017.
, “Preventing Delirium and Promoting Long-Term Brain Health: A Clinical Trial Design for the Perioperative Cognitive Enhancement (PROTECT) Trial.”, J Alzheimers Dis, vol. 83, no. 4, pp. 1637-1649, 2021.
,